Old | New | Differences | |
---|---|---|---|
1 | - | WES MOORE, Governor Ch. 924 | |
2 | 1 | ||
3 | - | – 1 – | |
4 | - | Chapter 924 | |
5 | - | (House Bill 51) | |
6 | 2 | ||
7 | - | AN ACT concerning | |
3 | + | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. | |
4 | + | [Brackets] indicate matter deleted from existing law. | |
5 | + | Underlining indicates amendments to bill. | |
6 | + | Strike out indicates matter stricken from the bill by amendment or deleted from the law by | |
7 | + | amendment. | |
8 | + | Italics indicate opposite chamber/conference committee amendments. | |
9 | + | *hb0051* | |
8 | 10 | ||
9 | - | Maryland Pediatric Cancer Fund – Modifications | |
10 | - | Public Health – Maryland Pediatric Cancer Fund and Commission | |
11 | + | HOUSE BILL 51 | |
12 | + | J1 (4lr1238) | |
13 | + | ENROLLED BILL | |
14 | + | — Health and Government Operations/Finance — | |
15 | + | Introduced by Delegate Rosenberg Delegates Rosenberg, Pena–Melnyk, Cullison, | |
16 | + | Alston, Bagnall, Bhandari, Chisholm, Guzzone, Hill, Hutchinson, | |
17 | + | S. Johnson, Kaiser, Kipke, R. Lewis, Lopez, Martinez, M. Morgan, Reilly, | |
18 | + | Szeliga, Taveras, White Holland, and Woods | |
11 | 19 | ||
12 | - | FOR the purpose of altering the use of the Maryland Pediatric Cancer Fund to require that | |
13 | - | the Fund be used only for pediatric cancer research instead of only for pediatric | |
14 | - | cancer research, prevention, and treatment and to allow funds from the Fund to be | |
15 | - | used for administrative expenses; establishing the Pediatric Cancer Research | |
16 | - | Commission to oversee the award of competitive grants from the Fund; and generally | |
17 | - | relating to the Maryland Pediatric Cancer Fund and the Pediatric Cancer Research | |
18 | - | Commission. | |
20 | + | Read and Examined by Proofreaders: | |
19 | 21 | ||
20 | - | BY repealing and reenacting, with amendments, | |
21 | - | Article – Health – General | |
22 | - | Section 20–120 | |
23 | - | Annotated Code of Maryland | |
24 | - | (2023 Replacement Volume) | |
22 | + | _______________________________________________ | |
23 | + | Proofreader. | |
24 | + | _______________________________________________ | |
25 | + | Proofreader. | |
25 | 26 | ||
26 | - | BY adding to | |
27 | - | Article – Health – General | |
28 | - | Section 20–121 | |
29 | - | Annotated Code of Maryland | |
30 | - | (2023 Replacement Volume) | |
27 | + | Sealed with the Great Seal and presented to the Governor, for his approval this | |
31 | 28 | ||
32 | - | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, | |
33 | - | That the Laws of Maryland read as follows: | |
29 | + | _______ day of _______________ at __________ ______________ o’clock, ________M. | |
34 | 30 | ||
35 | - | Article – Health – General | |
31 | + | ______________________________________________ | |
32 | + | Speaker. | |
36 | 33 | ||
37 | - | ||
34 | + | CHAPTER ______ | |
38 | 35 | ||
39 | - | ||
36 | + | AN ACT concerning 1 | |
40 | 37 | ||
41 | - | ||
42 | - | ||
38 | + | Maryland Pediatric Cancer Fund – Modifications 2 | |
39 | + | Public Health – Maryland Pediatric Cancer Fund and Commission 3 | |
43 | 40 | ||
44 | - | (3) “Pediatric cancer research” includes research to develop and advance | |
45 | - | the understanding of pediatric cancer and the techniques and modalities effective in the | |
46 | - | prevention, cure, screening, and treatment of pediatric cancer. | |
41 | + | FOR the purpose of altering the use of the Maryland Pediatric Cancer Fund to require that 4 | |
42 | + | the Fund be used only for pediatric cancer research instead of only for pediatric 5 | |
43 | + | cancer research, prevention, and treatment and to allow funds from the Fund to be 6 | |
44 | + | used for administrative expenses; establishing the Pediatric Cancer Research 7 | |
45 | + | Commission to oversee the award of competitive grants from the Fund; and generally 8 | |
46 | + | relating to the Maryland Pediatric Cancer Fund and the Pediatric Cancer Research 9 | |
47 | + | Commission. 10 | |
47 | 48 | ||
48 | - | (b) (1) There is a Maryland Pediatric Cancer Fund. | |
49 | - | Ch. 924 2024 LAWS OF MARYLAND | |
49 | + | BY repealing and reenacting, with amendments, 11 2 HOUSE BILL 51 | |
50 | 50 | ||
51 | - | – 2 – | |
52 | - | (2) The Fund consists of: | |
53 | 51 | ||
54 | - | (i) Money appropriated in the State budget to the Fund; and | |
52 | + | Article – Health – General 1 | |
53 | + | Section 20–120 2 | |
54 | + | Annotated Code of Maryland 3 | |
55 | + | (2023 Replacement Volume) 4 | |
55 | 56 | ||
56 | - | (ii) Any donations or other money from any other source accepted for | |
57 | - | the benefit of the Fund. | |
57 | + | BY adding to 5 | |
58 | + | Article – Health – General 6 | |
59 | + | Section 20–121 7 | |
60 | + | Annotated Code of Maryland 8 | |
61 | + | (2023 Replacement Volume) 9 | |
58 | 62 | ||
59 | - | (3) The Secretary shall administer the Fund. | |
63 | + | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 10 | |
64 | + | That the Laws of Maryland read as follows: 11 | |
60 | 65 | ||
61 | - | (4) The Fund shall be used only for pediatric cancer research AND | |
62 | - | ADMINISTRATIVE EXPEN SES[, prevention, and treatment] as provided in subsection (c) | |
63 | - | of this section. | |
66 | + | Article – Health – General 12 | |
64 | 67 | ||
65 | - | (5) The Fund shall be maintained for the purposes stated in this section | |
66 | - | and unspent portions of the Fund shall remain in the Fund and may not revert to the | |
67 | - | General Fund of the State. | |
68 | + | 20–120. 13 | |
68 | 69 | ||
69 | - | (6) Money expended from the Fund for pediatric cancer research [, | |
70 | - | prevention, and treatment] is supplemental and is not intended to take the place of funding | |
71 | - | that would otherwise be appropriated to the Department for pediatric cancer research[, | |
72 | - | prevention, and treatment]. | |
70 | + | (a) (1) In this section the following words have the meanings indicated. 14 | |
73 | 71 | ||
74 | - | (7) All expenditures from the Fund shall be made only in accordance with | |
75 | - | an appropriation approved by the General Assembly in the annual State budget or through | |
76 | - | an approved budget amendment under §§ 7–209 and 7–210 of the State Finance and | |
77 | - | Procurement Article. | |
72 | + | (2) “Fund” means the Maryland Pediatric Cancer Fund established under 15 | |
73 | + | this section. 16 | |
78 | 74 | ||
79 | - | (8) (i) For fiscal year 2023, the Governor shall include in the annual | |
80 | - | budget bill an appropriation of $5,000,000 to the Fund. | |
75 | + | (3) “Pediatric cancer research” includes research to develop and advance 17 | |
76 | + | the understanding of pediatric cancer and the techniques and modalities effective in the 18 | |
77 | + | prevention, cure, screening, and treatment of pediatric cancer. 19 | |
81 | 78 | ||
82 | - | (ii) If $5,000,000 is not included in the annual budget bill for fiscal | |
83 | - | year 2023, then the Governor shall include in the annual budget bill for fiscal year 2024 an | |
84 | - | appropriation of $5,000,000 to the Fund. | |
79 | + | (b) (1) There is a Maryland Pediatric Cancer Fund. 20 | |
85 | 80 | ||
86 | - | ( | |
81 | + | (2) The Fund consists of: 21 | |
87 | 82 | ||
88 | - | 1. DISTRIBUTE FUNDS FROM the Fund to a promotional | |
89 | - | account TO BE ALLOCATED TO A STATE–BASED CHILDHOOD CANC ER ORGANIZATION | |
90 | - | to be used to promote further donations to the Fund AND TO EDUCATE THE STATE | |
91 | - | SCIENTIFIC COMMUNITY ABOUT THE OPPORTUNIT IES FOR CHILDHOOD CA NCER | |
92 | - | RESEARCH THROUGH THE FUND; AND | |
83 | + | (i) Money appropriated in the State budget to the Fund; and 22 | |
93 | 84 | ||
94 | - | 2. USE FUNDS FROM THE FUND TO ADMINISTER TH E | |
95 | - | FUND, INCLUDING FOR STAFF AND ADMINISTRATIVE COSTS ASSOCIATED WITH THE | |
96 | - | COMMISSION ESTABLISHE D UNDER § 20–121 OF THIS SUBTITLE. WES MOORE, Governor Ch. 924 | |
85 | + | (ii) Any donations or other money from any other source accepted for 23 | |
86 | + | the benefit of the Fund. 24 | |
97 | 87 | ||
98 | - | ||
88 | + | (3) The Secretary shall administer the Fund. 25 | |
99 | 89 | ||
100 | - | ( | |
101 | - | ||
102 | - | ||
90 | + | (4) The Fund shall be used only for pediatric cancer research AND 26 | |
91 | + | ADMINISTRATIVE EXPEN SES[, prevention, and treatment] as provided in subsection (c) 27 | |
92 | + | of this section. 28 | |
103 | 93 | ||
104 | - | ( | |
105 | - | ||
106 | - | ||
107 | - | ||
94 | + | (5) The Fund shall be maintained for the purposes stated in this section 29 | |
95 | + | and unspent portions of the Fund shall remain in the Fund and may not revert to the 30 | |
96 | + | General Fund of the State. 31 | |
97 | + | HOUSE BILL 51 3 | |
108 | 98 | ||
109 | - | (ii) Money received from the grant program under this section may | |
110 | - | not be used to pay for institutional overhead expenses, organizational expenses, or charges | |
111 | - | that are not directly related to pediatric cancer research[, prevention, or treatment] or | |
112 | - | expenses arising from community–based support services. | |
113 | 99 | ||
114 | - | (d) (1) On or before August 31 each year, the Secretary shall submit a report | |
115 | - | to the General Assembly, in accordance with § 2–1257 of the State Government Article, on | |
116 | - | the administration of the Fund. | |
100 | + | (6) Money expended from the Fund for pediatric cancer research [, 1 | |
101 | + | prevention, and treatment] is supplemental and is not intended to take the place of funding 2 | |
102 | + | that would otherwise be appropriated to the Department for pediatric cancer research[, 3 | |
103 | + | prevention, and treatment]. 4 | |
117 | 104 | ||
118 | - | (2) The report required under this subsection shall include: | |
105 | + | (7) All expenditures from the Fund shall be made only in accordance with 5 | |
106 | + | an appropriation approved by the General Assembly in the annual State budget or through 6 | |
107 | + | an approved budget amendment under §§ 7–209 and 7–210 of the State Finance and 7 | |
108 | + | Procurement Article. 8 | |
119 | 109 | ||
120 | - | (i) | |
121 | - | the Fund | |
110 | + | (8) (i) For fiscal year 2023, the Governor shall include in the annual 9 | |
111 | + | budget bill an appropriation of $5,000,000 to the Fund. 10 | |
122 | 112 | ||
123 | - | (ii) A detailed accounting of the use of the Fund. | |
113 | + | (ii) If $5,000,000 is not included in the annual budget bill for fiscal 11 | |
114 | + | year 2023, then the Governor shall include in the annual budget bill for fiscal year 2024 an 12 | |
115 | + | appropriation of $5,000,000 to the Fund. 13 | |
124 | 116 | ||
125 | - | (e) The Secretary shall adopt regulations to implement a pediatric cancer grant | |
126 | - | program under this section. | |
117 | + | (c) (1) (I) Each year, the Secretary may distribute not more than 5% of: 14 | |
127 | 118 | ||
128 | - | 20–121. | |
119 | + | 1. DISTRIBUTE FUNDS FROM the Fund to a promotional 15 | |
120 | + | account TO BE ALLOCATED TO A STATE–BASED CHILDHOOD CANC ER ORGANIZATION 16 | |
121 | + | to be used to promote further donations to the Fund AND TO EDUCATE THE STATE 17 | |
122 | + | SCIENTIFIC COMMUNITY ABOUT THE OPPORTUNIT IES FOR CHILDHOOD CA NCER 18 | |
123 | + | RESEARCH THROUGH THE FUND; AND 19 | |
129 | 124 | ||
130 | - | (A) IN THIS SECTION , “COMMISSION” MEANS THE PEDIATRIC CANCER | |
131 | - | RESEARCH COMMISSION. | |
125 | + | 2. USE FUNDS FROM THE FUND TO ADMINISTER TH E 20 | |
126 | + | FUND, INCLUDING FOR STAFF AND ADMINISTRATIVE COSTS ASSOCIATED WITH THE 21 | |
127 | + | COMMISSION ESTABLISHE D UNDER § 20–121 OF THIS SUBTITLE. 22 | |
132 | 128 | ||
133 | - | (B) THERE IS A PEDIATRIC CANCER RESEARCH COMMISSION. | |
129 | + | (II) THE AMOUNTS DISTRIBUT ED AND USED UNDER 23 | |
130 | + | SUBPARAGRAPH (I) OF THIS PARAGRAPH MA Y NOT EXCEED A TOTAL OF 5% OF THE 24 | |
131 | + | FUND. 25 | |
134 | 132 | ||
135 | - | (C) THE PURPOSE OF THE COMMISSION IS TO OVER SEE THE AWARD OF | |
136 | - | COMPETITIVE GRANTS F ROM THE PEDIATRIC CANCER FUND, ESTABLISHED UNDER | |
137 | - | § 20–120 OF THIS SUBTITLE, TO PUBLIC AND PRIVAT E ENTITIES IN THE STATE. | |
133 | + | (2) (i) After making the distribution allowed under paragraph (1) of 26 | |
134 | + | this subsection, the Secretary shall use the remainder of the Fund only to provide grants 27 | |
135 | + | to eligible physicians, hospitals, laboratories, educational institutions, and other 28 | |
136 | + | organizations and persons to conduct pediatric cancer research[, prevention, or treatment]. 29 | |
138 | 137 | ||
139 | - | (D) THE COMMISSION CONSISTS O F: | |
138 | + | (ii) Money received from the grant program under this section may 30 | |
139 | + | not be used to pay for institutional overhead expenses, organizational expenses, or charges 31 | |
140 | + | that are not directly related to pediatric cancer research[, prevention, or treatment] or 32 | |
141 | + | expenses arising from community–based support services. 33 | |
142 | + | 4 HOUSE BILL 51 | |
140 | 143 | ||
141 | - | (1) THE SECRETARY OF HEALTH, OR THE SECRETARY’S DESIGNEE; | |
142 | - | AND | |
143 | - | Ch. 924 2024 LAWS OF MARYLAND | |
144 | 144 | ||
145 | - | – 4 – | |
146 | - | (2) THE FOLLOWING MEMBERS APPOINTED BY THE GOVERNOR: | |
145 | + | (d) (1) On or before August 31 each year, the Secretary shall submit a report 1 | |
146 | + | to the General Assembly, in accordance with § 2–1257 of the State Government Article, on 2 | |
147 | + | the administration of the Fund. 3 | |
147 | 148 | ||
148 | - | (I) TWO INDIVIDUALS WHO A RE ADULT SURVIVORS O F | |
149 | - | PEDIATRIC CANCER OR CAREGIVERS OF PEDIAT RIC CANCER PATIENTS , FROM A LIST | |
150 | - | SUBMITTED BY WHO MAY BE IDENTIFIED IN CONSULTATION WITH THE AMERICAN | |
151 | - | CHILDHOOD CANCER ORGANIZATION; | |
149 | + | (2) The report required under this subsection shall include: 4 | |
152 | 150 | ||
153 | - | ( | |
154 | - | ||
151 | + | (i) A description of promotional efforts undertaken with money from 5 | |
152 | + | the Fund; and 6 | |
155 | 153 | ||
156 | - | (III) TWO FOUR SCIENTISTS WITH EXPE RTISE IN PEDIATRIC | |
157 | - | CANCER RESEARCH FROM THE UNIVERSITY OF MARYLAND; | |
154 | + | (ii) A detailed accounting of the use of the Fund. 7 | |
158 | 155 | ||
159 | - | ( | |
160 | - | ||
156 | + | (e) The Secretary shall adopt regulations to implement a pediatric cancer grant 8 | |
157 | + | program under this section. 9 | |
161 | 158 | ||
162 | - | (V) (IV) TWO ADVANCED PRACTICE REGISTERED NURSES | |
163 | - | WHO HAVE EXPERIENCE IN PEDIATRIC CANCER CARE; AND | |
159 | + | 20–121. 10 | |
164 | 160 | ||
165 | - | (VI) (V) ONE PHYSICIAN THREE PHYSICIANS WITH EXPERTISE | |
166 | - | IN TREATING PEDIATRI C CANCER PATIENTS FROM THE UNIVERSITY OF MARYLAND | |
167 | - | MEDICAL SYSTEM; | |
161 | + | (A) IN THIS SECTION , “COMMISSION” MEANS THE PEDIATRIC CANCER 11 | |
162 | + | RESEARCH COMMISSION. 12 | |
168 | 163 | ||
169 | - | (VII) ONE PHYSICIAN WITH EX PERTISE IN TREATING PEDIATRIC | |
170 | - | CANCER PATIENTS FROM JOHNS HOPKINS MEDICINE; | |
164 | + | (B) THERE IS A PEDIATRIC CANCER RESEARCH COMMISSION. 13 | |
171 | 165 | ||
172 | - | (VIII) ONE PHYSICIAN WITH EX PERTISE IN PEDIATRIC ONCOLOGY | |
173 | - | FROM LIFEBRIDGE HEALTH; AND | |
166 | + | (C) THE PURPOSE OF THE COMMISSION IS TO OVER SEE THE AWARD OF 14 | |
167 | + | COMPETITIVE GRANTS F ROM THE PEDIATRIC CANCER FUND, ESTABLISHED UNDER 15 | |
168 | + | § 20–120 OF THIS SUBTITLE, TO PUBLIC AND PRIVAT E ENTITIES IN THE STATE. 16 | |
174 | 169 | ||
175 | - | (IX) ONE INDIVIDUAL WITH E XPERTISE IN PEDIATRI C | |
176 | - | ONCOLOGY FROM THE NATIONAL CANCER INSTITUTE. | |
170 | + | (D) THE COMMISSION CONSISTS O F: 17 | |
177 | 171 | ||
178 | - | (E) (1) THE TERM OF AN APPOIN TED MEMBER IS 3 YEARS. | |
172 | + | (1) THE SECRETARY OF HEALTH, OR THE SECRETARY’S DESIGNEE; 18 | |
173 | + | AND 19 | |
179 | 174 | ||
180 | - | (2) THE TERMS OF THE APPO INTED MEMBERS OF THE COMMISSION | |
181 | - | ARE STAGGERED AS REQ UIRED BY THE TERMS P ROVIDED FOR MEMBERS OF THE | |
182 | - | COMMISSION ON OCTOBER 1, 2024. | |
175 | + | (2) THE FOLLOWING MEMBERS APPOINTED BY THE GOVERNOR: 20 | |
183 | 176 | ||
184 | - | ( | |
185 | - | ||
186 | - | THE | |
187 | - | ||
177 | + | (I) TWO INDIVIDUALS WHO A RE ADULT SURVIVORS O F 21 | |
178 | + | PEDIATRIC CANCER OR CAREGIVERS OF PEDIAT RIC CANCER PATIENTS , FROM A LIST 22 | |
179 | + | SUBMITTED BY WHO MAY BE IDENTI FIED IN CONSULTATION WITH THE AMERICAN 23 | |
180 | + | CHILDHOOD CANCER ORGANIZATION; 24 | |
188 | 181 | ||
189 | - | – 5 – | |
190 | - | (4) AT THE END OF A TERM , A MEMBER MAY CONTINU E TO SERVE | |
191 | - | ONLY UNTIL A SUCCESS OR IS APPOINTED AND QUALIFIES. | |
182 | + | (II) ONE REPRESENTATIVE OF THE AMERICAN CHILDHOOD 25 | |
183 | + | CANCER ORGANIZATION; 26 | |
192 | 184 | ||
193 | - | (5) A MEMBER WHO IS APPOIN TED AFTER A TERM HAS BEGUN SERVES | |
194 | - | ONLY FOR THE REST OF THE TERM AND UNTIL A SUCCESSOR IS APPOINT ED AND | |
195 | - | QUALIFIES. | |
185 | + | (III) TWO FOUR SCIENTISTS WITH EXPE RTISE IN PEDIATRIC 27 | |
186 | + | CANCER RESEARCH FROM THE UNIVERSITY OF MARYLAND; 28 | |
196 | 187 | ||
197 | - | ( | |
198 | - | ||
188 | + | (IV) TWO SCIENTISTS WITH E XPERTISE IN PEDIATRI C CANCER 29 | |
189 | + | RESEARCH FROM JOHNS HOPKINS UNIVERSITY; 30 HOUSE BILL 51 5 | |
199 | 190 | ||
200 | - | (F) EACH MEMBER OF THE COMMISSION SHALL DISC LOSE TO THE STATE | |
201 | - | ETHICS COMMISSION WHETHER TH E MEMBER IS EMPLOYED BY OR HAS A FINANCIA L | |
202 | - | INTEREST IN AN ENTIT Y THAT MAY APPLY TO CONDUCT STATE–FUNDED PEDIATRIC | |
203 | - | CANCER RESEARCH . | |
204 | 191 | ||
205 | - | (G) (1) THE GOVERNOR MAY REMOVE A MEMBER FOR NEGLECT O F DUTY, | |
206 | - | INCOMPETENCE , MISCONDUCT , MALFEASANCE , MISFEASANCE , NONFEASANCE , OR | |
207 | - | ANY OTHER SUFFICIENT CAUSE. | |
208 | 192 | ||
209 | - | ( | |
210 | - | ||
193 | + | (V) (IV) TWO ADVANCED PRACTICE REGISTERED NURSES 1 | |
194 | + | WHO HAVE EXPERIENCE IN PEDIATRIC CANCER CARE; AND 2 | |
211 | 195 | ||
212 | - | (H) (1) A MAJORITY OF THE FULL AUTHORIZED MEMBERSHI P OF THE | |
213 | - | COMMISSION IS A QUORU M. | |
196 | + | (VI) (V) ONE PHYSICIAN THREE PHYSICIANS WITH EXPERTISE 3 | |
197 | + | IN TREATING PEDIATRI C CANCER PATIENTS FROM THE UNIVERSITY OF MARYLAND 4 | |
198 | + | MEDICAL SYSTEM; 5 | |
214 | 199 | ||
215 | - | ( | |
216 | - | ||
200 | + | (VII) ONE PHYSICIAN WITH EX PERTISE IN TREATING PEDIATRIC 6 | |
201 | + | CANCER PATIENTS FROM JOHNS HOPKINS MEDICINE; 7 | |
217 | 202 | ||
218 | - | ( | |
219 | - | AND | |
203 | + | (VIII) ONE PHYSICIAN WITH EX PERTISE IN PEDIATRIC ONCOLOGY 8 | |
204 | + | FROM LIFEBRIDGE HEALTH; AND 9 | |
220 | 205 | ||
221 | - | (J) A MEMBER OF THE COMMISSION: | |
206 | + | (IX) ONE INDIVIDUAL WITH E XPERTISE IN PEDIATRI C 10 | |
207 | + | ONCOLOGY FROM THE NATIONAL CANCER INSTITUTE. 11 | |
222 | 208 | ||
223 | - | (1) MAY NOT RECEIVE COMPE NSATION AS A MEMBER OF THE | |
224 | - | COMMISSION; BUT | |
209 | + | (E) (1) THE TERM OF AN APPOIN TED MEMBER IS 3 YEARS. 12 | |
225 | 210 | ||
226 | - | (2) IS ENTITLED TO REIMBU RSEMENT FOR EXPENSES UNDER THE | |
227 | - | STANDARD STATE TRAVEL REGULATIONS, AS PROVIDED IN THE STATE BUDGET. | |
211 | + | (2) THE TERMS OF THE AP POINTED MEMBERS OF T HE COMMISSION 13 | |
212 | + | ARE STAGGERED AS REQ UIRED BY THE TERMS P ROVIDED FOR MEMBERS OF THE 14 | |
213 | + | COMMISSION ON OCTOBER 1, 2024. 15 | |
228 | 214 | ||
229 | - | (K) THE COMMISSION ANNUALLY S HALL ELECT A CHAIR A ND VICE CHAIR | |
230 | - | FROM AMONG ITS MEMBE RS. | |
215 | + | (3) IF A VACANCY OCCURS D URING THE TERM OF AN APPOINTED 16 | |
216 | + | MEMBER, THE GOVERNOR SHALL APPOIN T A SUCCESSOR WHO SH ALL SERVE UN TIL 17 | |
217 | + | THE TERM EXPIRES . 18 | |
231 | 218 | ||
232 | - | ( | |
233 | - | ||
219 | + | (4) AT THE END OF A TERM , A MEMBER MAY CONTINU E TO SERVE 19 | |
220 | + | ONLY UNTIL A SUCCESS OR IS APPOINTED AND QUALIFIES. 20 | |
234 | 221 | ||
235 | - | – 6 – | |
236 | - | (1) DEVELOP CRITERIA , STANDARDS, AND REQUIREMENTS FOR THE | |
237 | - | REVIEW OF APPLICATIO NS FOR PEDIATRIC CAN CER RESEARCH GRANTS FROM THE | |
238 | - | PEDIATRIC CANCER FUND; | |
222 | + | (5) A MEMBER WHO IS APPOIN TED AFTER A TERM HAS BEGUN SERVES 21 | |
223 | + | ONLY FOR THE REST OF THE TERM AND UNTIL A SUCCESSOR IS APPO INTED AND 22 | |
224 | + | QUALIFIES. 23 | |
239 | 225 | ||
240 | - | (2) ESTABLISH PROCEDURES AND GUIDELINES TO BE USED IN THE | |
241 | - | REVIEW, EVALUATION, RANKING, AND RATING OF THE RE SEARCH GRANT | |
242 | - | PROPOSALS; | |
226 | + | (6) A MEMBER MAY NOT SERVE MORE THAN TWO CONSEC UTIVE FULL 24 | |
227 | + | TERMS. 25 | |
243 | 228 | ||
244 | - | (3) REVIEW DEVELOP CRITERIA AND A PROCESS FOR REVIEW ING | |
245 | - | GRANT APPLICATIONS T O ENSURE THAT EACH APPLICATION IS COMPLETE AND | |
246 | - | SATISFIES THE CRITER IA, STANDARDS, AND REQUIREMENTS DEV ELOPED BY THE | |
247 | - | COMMISSION UNDER ITEM (1) OF THIS SUBSECTION ; | |
229 | + | (F) EACH MEMBER OF THE COMMISSION SHALL DISC LOSE TO THE STATE 26 | |
230 | + | ETHICS COMMISSION WHETHER TH E MEMBER IS EMPLOYED BY OR HAS A FINANCIA L 27 | |
231 | + | INTEREST IN AN ENTIT Y THAT MAY APPLY TO CONDUCT STATE–FUNDED PEDIATRIC 28 | |
232 | + | CANCER RESEARCH . 29 | |
233 | + | 6 HOUSE BILL 51 | |
248 | 234 | ||
249 | - | (4) DEVELOP DISCLOSURE AN D RECUSAL GUIDELINES TO BE | |
250 | - | FOLLOWED BY MEMBERS OF THE COMMISSION WHEN CONSI DERING GRANT | |
251 | - | APPLICATIONS; | |
252 | 235 | ||
253 | - | (5) ESTABLISH STANDARDS F OR THE OVERSIGHT OF AWARDS; AND | |
236 | + | (G) (1) THE GOVERNOR MAY REMOVE A MEMBER FOR NEGLECT O F DUTY, 1 | |
237 | + | INCOMPETENCE , MISCONDUCT , MALFEASANCE , MISFEASANCE , NONFEASANCE , OR 2 | |
238 | + | ANY OTHER SUFFICIENT CAUSE. 3 | |
254 | 239 | ||
255 | - | (6) CONDUCT PROGRESS REVI EWS OF GRANT RECIPIE NTS. | |
240 | + | (2) THE GOVERNOR MAY NOT REMO VE A MEMBER FOR POLITICAL 4 | |
241 | + | PARTY PREFERENCE . 5 | |
256 | 242 | ||
257 | - | ( | |
258 | - | ||
243 | + | (H) (1) A MAJORITY OF THE FULL AUTHORIZED MEMBERSHI P OF THE 6 | |
244 | + | COMMISSION IS A QUORU M. 7 | |
259 | 245 | ||
260 | - | | |
261 | - | ||
246 | + | (2) THE DECISION OF THE COMMISSION SHALL BE B Y A MAJORITY OF 8 | |
247 | + | THE QUORUM PRESENT A ND VOTING. 9 | |
262 | 248 | ||
263 | - | (1) four members in 2025; | |
249 | + | (I) THE COMMISSION SHALL MEET AT LEAST TWICE A YEAR , AT THE TIMES 10 | |
250 | + | AND PLACES THAT IT D ETERMINES. 11 | |
264 | 251 | ||
265 | - | ( | |
252 | + | (J) A MEMBER OF THE COMMISSION: 12 | |
266 | 253 | ||
267 | - | (3) five four members in 2027. | |
254 | + | (1) MAY NOT RECEIVE COMPE NSATION AS A MEMBER OF THE 13 | |
255 | + | COMMISSION; BUT 14 | |
268 | 256 | ||
269 | - | | |
270 | - | ||
257 | + | (2) IS ENTITLED TO REIMBU RSEMENT FOR EXPENSES UNDER THE 15 | |
258 | + | STANDARD STATE TRAVEL REGULATIONS, AS PROVIDED IN THE STATE BUDGET . 16 | |
271 | 259 | ||
272 | - | Approved by the Governor, May 16, 2024. | |
260 | + | (K) THE COMMISSION ANNUALLY S HALL ELECT A CHAIR A ND VICE CHAIR 17 | |
261 | + | FROM AMONG ITS MEMBE RS. 18 | |
262 | + | ||
263 | + | (L) THE COMMISSION SHALL : 19 | |
264 | + | ||
265 | + | (1) DEVELOP CRITERIA , STANDARDS, AND REQUIREMENTS FOR THE 20 | |
266 | + | REVIEW OF APPLICATIO NS FOR PEDIATRIC C ANCER RESEARCH GRANT S FROM THE 21 | |
267 | + | PEDIATRIC CANCER FUND; 22 | |
268 | + | ||
269 | + | (2) ESTABLISH PROCEDURES AND GUIDELINES TO BE USED IN THE 23 | |
270 | + | REVIEW, EVALUATION, RANKING, AND RATING OF THE RE SEARCH GRANT 24 | |
271 | + | PROPOSALS; 25 | |
272 | + | ||
273 | + | (3) REVIEW DEVELOP CRITERIA AND A PROCESS FOR REVIEW ING 26 | |
274 | + | GRANT APPLICATIONS TO ENSU RE THAT EACH APPLICA TION IS COMPLETE AND 27 | |
275 | + | SATISFIES THE CRITER IA, STANDARDS, AND REQUIREMENTS DEV ELOPED BY THE 28 | |
276 | + | COMMISSION UNDER ITEM (1) OF THIS SUBSECTION ; 29 | |
277 | + | HOUSE BILL 51 7 | |
278 | + | ||
279 | + | ||
280 | + | (4) DEVELOP DISCLOSURE AN D RECUSAL GUIDELINES TO BE 1 | |
281 | + | FOLLOWED BY MEMBERS OF THE COMMISSION WHEN CONSI DERING GRANT 2 | |
282 | + | APPLICATIONS; 3 | |
283 | + | ||
284 | + | (5) ESTABLISH STANDARDS F OR THE OVERSIGHT OF AWARDS; AND 4 | |
285 | + | ||
286 | + | (6) CONDUCT PROGRESS REVI EWS OF GRANT RECIPIE NTS. 5 | |
287 | + | ||
288 | + | (M) THE COMMISSION MAY CONSUL T WITH EXPERTS IN PE RFORMING ITS 6 | |
289 | + | DUTIES. 7 | |
290 | + | ||
291 | + | SECTION 2. AND BE IT FURTHER ENACTED, That the terms of the initial 8 | |
292 | + | members of the Pediatric Cancer Research Commission shall expire as follows: 9 | |
293 | + | ||
294 | + | (1) four members in 2025; 10 | |
295 | + | ||
296 | + | (2) four members in 2026; and 11 | |
297 | + | ||
298 | + | (3) five four members in 2027. 12 | |
299 | + | ||
300 | + | SECTION 2. 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 13 | |
301 | + | October 1, 2024. 14 | |
302 | + | ||
303 | + | ||
304 | + | ||
305 | + | ||
306 | + | Approved: | |
307 | + | ________________________________________________________________________________ | |
308 | + | Governor. | |
309 | + | ________________________________________________________________________________ | |
310 | + | Speaker of the House of Delegates. | |
311 | + | ________________________________________________________________________________ | |
312 | + | President of the Senate. |